Development of real-time reverse transcriptase qPCR assays for the detection of Punta Toro virus and Pichinde virus

Virology Journal

Volumn 13, Issue 1, 2016, Pages

  Stefan, Christopher P ^a   Chase, Kitty ^a   Coyne, Susan ^a   Kulesh, David A ^a   Minogue, Timothy D ^a   Koehler, Jeffrey W ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Arenaviruses; Bunyaviruses; Pichinde virus; Punta Toro virus; Real time RT qPCR

Indexed keywords

NUCLEIC ACID; VIRUS RNA;

ARTICLE; BLOOD; CROSS REACTION; DIAGNOSTIC KIT; DILUTION; LIMIT OF DETECTION; NONHUMAN; NUCLEIC ACID ANALYSIS; PERFORMANCE MEASUREMENT SYSTEM; PICHINDE VIRUS; PROCESS OPTIMIZATION; PROTEIN TARGETING; PUNTA TORO VIRUS; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SANGER SEQUENCING; SENSITIVITY AND SPECIFICITY; SERUM; VERO CELL LINE; VERO E6 CELL; VIRUS DETECTION; VIRUS REPLICATION; ARENAVIRIDAE INFECTIONS; BUNYAVIRIDAE INFECTIONS; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PHLEBOVIRUS; PROCEDURES; TIME FACTOR; VIROLOGY;

ARENAVIRIDAE INFECTIONS; BUNYAVIRIDAE INFECTIONS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PHLEBOVIRUS; PICHINDE VIRUS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VIROLOGY;

EID: 85007571956     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-016-0509-3     Document Type: Article

References (29)

1. Adam AA, Karsany MS, Adam I. Manifestations of severe Rift Valley fever in Sudan. Int J Infect Dis. 2009; 14: e179-180.
2. Akane A, Matsubara K, Nakamura H, Takahashi S, Kimura K. Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification. J Forensic Sci. 1994; 39: 362-72.
3. Anderson Jr GW, Slayter MV, Hall W, Peters CJ. Pathogenesis of a phleboviral infection (Punta Toro virus) in golden Syrian hamsters. Arch Virol. 1990; 114: 203-12.
4. Bartelloni PJ, Tesh RB. Clinical and serologic responses of volunteers infected with phlebotomus fever virus (Sicilian type). Am J Trop Med Hyg. 1976; 25: 456-62.
5. Birmingham K, Kenyon G. Lassa fever is unheralded problem in West Africa. Nat Med. 2001; 7: 878.
6. Buchmeier MJ, Rawls WE. Variation between strains of hamsters in the lethality of Pichinde virus infections. Infect Immun. 1977; 16: 413-21.
7. Buckley SM, Casals J, Downs WG. Isolation and antigenic characterization of Lassa virus. Nature. 1970; 227: 174.
8. Daubney R, Hudson J, Garnham P. Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep, cattle and man from East Africa. J Path Bact. 1931; 34: 545-79.
9. Digoutte JP, Peters CJ. General aspects of the 1987 Rift Valley fever epidemic in Mauritania. Res Virol. 1989; 140: 27-30.
10. Durand JP, Bouloy M, Richecoeur L, Peyrefitte CN, Tolou H. Rift Valley fever virus infection among French troops in Chad. Emerg Infect Dis. 2003; 9: 751-2.
11. Fisher AF, Tesh RB, Tonry J, Guzman H, Liu D, Xiao SY. Induction of severe disease in hamsters by two sandfly fever group viruses, Punta toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus. Am J Trop Med Hyg. 2003; 69: 269-76.
12. Gowen BB, Barnard DL, Smee DF, Wong MH, Pace AM, Jung KH, Winslow SG, Bailey KW, Blatt, LM, Sidwell, RW. Interferon alfacon-1 protects hamsters from lethal pichinde virus infection. Antimicrob Agents Chemother. 2005; 49: 2378-86.
13. Gowen BB, Hoopes JD, Wong MH, Jung KH, Isakson KC, Alexopoulou L, Flavell RA, Sidwell RW. TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. J Immunol. 2006a; 177: 6301-7.
14. Gowen BB, Smee DF, Wong MH, Pace AM, Jung KH, Bailey KW, Blatt LM, Sidwell RW. Combinatorial ribavirin and interferon alfacon-1 therapy of acute arenaviral disease in hamsters. Antivir Chem Chemother. 2006c; 17: 175-83.
15. Jahrling PB, Hesse RA, Rhoderick JB, Elwell MA, Moe JB. Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs. Infect Immun. 1981; 32: 872-80.
16. Kramvis A, Bukofzer S, Kew MC. Comparison of hepatitis B virus DNA extractions from serum by the QIAamp blood kit, GeneReleaser, and the phenol-chloroform method. J Clin Microbiol. 1996; 34: 2731-3.
17. Liang Y, Lan S, Ly H. Molecular determinants of Pichinde virus infection of guinea pigs-a small animal model system for arenaviral hemorrhagic fevers. Ann N Y Acad Sci. 2009; 1171(Suppl 1): E65-74.
18. Lihoradova OA, Indran SV, Kalveram B, Lokugamage N, Head JA, Gong B, Tigabu B, Juelich TL, Freiberg AN, Ikegami T. Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus. PLoS Negl Trop Dis. 2013; 7: e2181.
19. Lucia HL, Coppenhaver DH, Baron S. Arenavirus infection in the guinea pig model: Antiviral therapy with recombinant interferon-alpha, the immunomodulator CL246, 738 and ribavirin. Antiviral Res. 1989; 12: 279-92.
20. Lukashevich IS. The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines. 2013; 12: 71-86.
21. Madani TA, Al-Mazrou YY, Al-Jeffri MH, Mishkhas AA, Al-Rabeah AM, Turkistani AM, Al-Sayed MO, Abodahish AA, Khan AS, Ksiazek TG, Shobokshi O. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis. 2003; 37: 1084-92.
22. Meegan JM, Hoogstraal H, Moussa MI. An epizootic of Rift Valley fever in Egypt in 1977. Vet Rec. 1979; 105: 124-5.
23. Monteiro L, Bonnemaison D, Vekris A, Petry KG, Bonnet J, Vidal R, Cabrita J, Megraud F. Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J Clin Microbiol. 1997; 35: 995-8.
24. Perrone LA, Narayanan K, Worthy M, Peters CJ. The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist. J Virol. 2007; 81: 884-92.
25. Shoemaker T, Boulianne C, Vincent MJ, Pezzanite L, Al-Qahtani MM, Al-Mazrou Y, Khan A. S, Rollin PE, Swanepoel R, Ksiazek TG, Nichol ST. Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01. Emerg Infect Dis. 2002; 8: 1415-20.
26. Smee DF, Gilbert J, Leonhardt JA, Barnett BB, Huggins JH, Sidwell RW. Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen. Antiviral Res. 1993; 20: 57-70.
27. Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, Schoepp RJ, Norwood DA, Goba A, Fair JN, Kulesh DA. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. 2010; 82: 954-60.
28. Widjojoatmodjo MN, Fluit AC, Torensma R, Verdonk GP, Verhoef J. The magnetic immuno polymerase chain reaction assay for direct detection of salmonellae in fecal samples. J Clin Microbiol. 1992; 30: 3195-9.
29. Xu F, Liu D, Nunes MR, AP DAR, Tesh RB, Xiao SY. Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae). Am J Trop Med Hyg. 2009; 76: 1194-200.